Treatment of rheumatoid arthritis with interleukin 1 receptor antagonist (Q33782376)

29 July 2017

1 reference

title

Treatment of rheumatoid arthritis with interleukin 1 receptor antagonist (English)

1 reference

29 July 2017

1 reference

Bresnihan B

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

Annals of the Rheumatic Diseases

29 July 2017

published in

1 reference

29 July 2017

volume

58 Suppl 1

1 reference

29 July 2017

page(s)

I96-8

1 reference

Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766566

Lessons for joint destruction from animal models

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766566

Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766566

Biologic basis for interleukin-1 in disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766566

The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766566

Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766566

Rheumatoid arthritis. Pathophysiology and implications for therapy

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766566

Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766566

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766566

Recombinant human interleukin-1 receptor type I in the treatment of patients with active rheumatoid arthritis

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10577983

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10577983

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. The IL-1Ra Arthritis Study Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10577983

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/ARD.58.2008.I96

1 reference

29 July 2017

1 reference

29 July 2017

1 reference